Interested in our current clinical study for cats with osteoarthritis? 

We are currently running a pivotal study assessing frunevetmab at approximately 20 clinics around the United States. Frunevetmab is our therapy in development for the control of pain associated with osteoarthritis in cats. For more information, including how to enrol your cat, see the bottom of our page on frunevetmab.

We’re passionate about animal healthcare, and want to share that passion.

We are committed to the highest ethical and scientific standards in our work, which is why we work closely with veterinarians and regulatory agencies across the world to make sure our final products will meet the high safety and efficacy requirements for approval.

Creating a new therapy to these standards takes time, and we know many pet owners out there hope to see new therapies available as soon as possible. We’re working hard to make our vision of better healthcare a reality.

In the meantime, please register to receive our newsletter, and follow us on social media to hear our news and thoughts as they happen, and gain further insights into animal health and biotechnology.

Nexvet Biopharma

Unit 5, Sragh Technology Park
Rahan Road, Tullamore
Co. Offaly, R35 FR98
P: + 353 5793 24522 

Level 8, 31 Queen Street
Melbourne 3000
P: +61 (3) 9610 4400

Get in Touch